1. Home
  2. KNSL vs TECH Comparison

KNSL vs TECH Comparison

Compare KNSL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kinsale Capital Group Inc.

KNSL

Kinsale Capital Group Inc.

N/A

Current Price

$365.88

Market Cap

9.2B

Sector

Finance

ML Signal

N/A

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

N/A

Current Price

$55.06

Market Cap

10.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSL
TECH
Founded
2009
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
10.2B
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
KNSL
TECH
Price
$365.88
$55.06
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
$455.40
$73.09
AVG Volume (30 Days)
266.5K
2.1M
Earning Date
05-15-2026
05-06-2026
Dividend Yield
0.27%
0.59%
EPS Growth
21.77
N/A
EPS
21.65
0.49
Revenue
$1,873,987,000.00
$1,219,635,000.00
Revenue This Year
$6.46
$2.49
Revenue Next Year
$8.77
$6.40
P/E Ratio
$17.24
$109.96
Revenue Growth
18.04
5.23
52 Week Low
$341.06
$46.02
52 Week High
$512.76
$72.16

Technical Indicators

Market Signals
Indicator
KNSL
TECH
Relative Strength Index (RSI) 37.91 36.26
Support Level $345.03 $48.52
Resistance Level $400.98 $58.88
Average True Range (ATR) 10.10 2.33
MACD -1.18 -0.26
Stochastic Oscillator 9.53 32.60

Price Performance

Historical Comparison
KNSL
TECH

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: